VRS on the TSX Venture Exchange $ 0.41
info@verisante.com
604 605 0507 Contact Info
ISO 13485:2003 CERTIFIED
December 16, 2010 at 11:05 am
T-Ray Science, Inc. Approved for BC Tax Credit Program
Investors eligible for 30 percent tax credit Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (the “Company” or “T-Ray”) announced today that it has been approved by British Columbia’s Ministry of Finance for its Venture Capital Program, which offers significant tax credits to investors in early-stage B.C.-based companies. Under the...
Full story
November 29, 2010 at 1:45 pm
T-Ray Science Completes Private Placement
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announces that it has completed a private placement of 1,250,000 units (“Units”) at a price of $0.20 per Unit for gross proceeds of $250,000. Each Unit consists of one common share of the Company and one half common share purchase warrant, each full...
Full story
November 16, 2010 at 5:38 pm
T-Ray Science, Inc. Licenses Lung Cancer Detection Technology From The BC Cancer Agency
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (the “Company” or “T-Ray”) announced today that it has entered into an exclusive licensing agreement with the BC Cancer Agency for rights to a device for the early detection of lung cancer. T-Ray previously announced it had obtained the rights to the device...
Full story
October 5, 2010 at 6:38 pm
T-Ray Science, Inc. Enters Collaborative Research Agreement With The BC Cancer Agency And Announces Milestones
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (the “Company” or “T-Ray”) announces it has entered into a Collaborative Research Agreement (“CRA”) with the BC Cancer Agency to assist in the production of several clinical prototypes of the skin cancer detection device which the Company licensed from the BC Cancer...
Full story
September 30, 2010 at 6:38 pm
T-Ray Science, Inc. Profiled On CTV News
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (the “Company” or “T-Ray”) announces the technology behind the skin cancer detector the Company is in the process of commercializing was recently profiled by Dr. Rhonda Low of CTV News. This device will greatly aid doctors in assessing skin lesions, providing...
Full story
September 21, 2010 at 6:37 pm
T-Ray Science, Inc. Files US Non Provisional Patent
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announces it has filed a non provisional patent with the U.S. Patent and Trade Mark Office on a Unified Sensing Matrix for a Single Pixel Detector Based on Compressive Sensing (USPTO Serial No. 61/243,559). T-Ray’s Patent covers a particular process of...
Full story
August 26, 2010 at 4:00 pm
T-Ray Science, Inc. Announces Product Development Team
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announces it has entered into consulting agreements with an engineering project management team for the development of the Company’s skin cancer detection device exclusively licensed from the BC Cancer Agency. Dr. Branko Palcic, formerly of the BC Cancer Agency and founder...
Full story
August 18, 2010 at 8:41 pm
T-Ray Science, Inc. Announces Reorganization
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announces a reorganization to consolidate management and administration. The Company reports that it has adopted a plan of reorganization which will result in a net savings of approximately $500,000 in cash expenditures over the next 12 months on general and administrative...
Full story
August 12, 2010 at 8:41 pm
T-Ray Science, Inc. Closes Oversubscribed Private Placement
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announces that further to its press release of July 14, 2010, it has completed its previously announced private placement of 3,000,000 units (“Units”) at a price of $0.22 per Unit. The Company reports that the private placement has been over-subscribed by 520,955 Units,...
Full story
July 16, 2010 at 8:41 pm
T-Ray Science, Inc. Announces Results Of Annual General Meeting
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announces that its annual general meeting of shareholders was held on July 15, 2010. Shareholders elected Joe Biegel, Karen Boodram, Ralph Braun, Thomas Braun, Chris Dennis and Jake Thiessen as directors. Thomas Braun is T-Ray’s CEO, Ralph Braun is T-Ray’s CFO,...
Full story
July 14, 2010 at 8:41 pm
T-Ray Science, Inc. Announces Non-Brokered Private Placement
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announces that it intends to complete a non-brokered private placement of up to 3,000,000 units at a price of $0.22 per unit for proceeds of up to $660,000 (the “Offering”). Each unit will comprise of one common share and one half common share...
Full story
July 12, 2010 at 8:40 pm
BC Cancer Agency Grants Skin Cancer Detection Rights To T-Ray Science, Inc.
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) announced today it has entered into an exclusive licensing agreement (the “Agreement”) with the BC Cancer Agency (“BCCA”) for patent rights to a novel, non-invasive skin cancer detection device that will accelerate T-Ray’s efforts in skin cancer diagnosis and treatment. The Company...
Full story
July 6, 2010 at 8:40 pm
T-Ray Science, Inc. Grants Technology Sub-License To Teraview Ltd.
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (“T-Ray Science” or the “Company”) is pleased to announce that it has granted a Sub-Licensing Agreement to TeraView Ltd. (“TeraView”), of Cambridge, UK, to use certain continuous wave (“CW”) TeraHertz (“THz”) technology, originally patented by MIT, and licensed exclusively to T-Ray Science....
Full story
June 28, 2010 at 8:40 pm
T-Ray Announces Addition To Board Of Directors And Expansion Of Its Investor Relations Program
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (“T-Ray” or the “Company”), announced today that Mr. Joseph Biegel has been nominated to the T-Ray board of directors to stand for election at the Company’s Annual General Meeting on July 15, 2010. Mr. Biegel is currently the Vice President of...
Full story
June 8, 2010 at 8:38 pm
T-Ray Science, Inc. Announces Prototype Counterfeit Drug Detector
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (“T-Ray Science” or the “Company”), announces a milestone achievement with the completion of the pre-production prototype of Authenticare™, a pharmaceutical tablet analyzer for the authentication of solid dosage pharmaceuticals. The target markets for the device are pharmacies, consumers, law enforcement, corporate security,...
Full story
May 27, 2010 at 8:36 pm
T-Ray Science, Inc. Announces Management Appointments
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (“T-Ray” or the “Company”), a pioneer in the development of a new modality for early skin cancer detection, announced today Tom Walker has been promoted to Chief Business Development Officer and Jeff Hendrikse has been appointed to Vice President of Product Development....
Full story
April 29, 2010 at 8:36 pm
T-Ray Science, Inc. Grants Technology License To Toptica Photonics, Inc.
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (“T-Ray” or the “Company”) an emerging leader in the field of TeraHertz (“THz”) research, is pleased to announce that it has granted a Licensing Agreement to Toptica Photonics, Inc. (“Toptica”). Toptica is a global market leader for THz sources and their...
Full story
February 9, 2010 at 7:36 pm
T-Ray Science, Inc. Announces Collaboration With The University Of Leeds And Engagement Of Investor Relations Firm
Vancouver, Canada: T-Ray Science, Inc. (TSX-V: THZ) (“T-Ray” or the “Company”), an emerging leader in the field of TeraHertz ("THz") research, today announced that it has entered into a research collaboration with the University of Leeds to develop low cost, pulsed and continuous wave (“CW”), fibre coupled terahertz (THz)...
Full story
January 18, 2010 at 7:36 pm
T-Ray Science, Inc. Announces Changes In Management
Vancouver, Canada: T-Ray Science Inc. (“T-Ray” or the “Company” TSXV: THZ) announced today that Tom Walker is joining T-Ray as the Company’s Senior Vice President of Business Development. Mr. Walker has over 25 years of North American and International experience in healthcare markets, including senior management roles with Eli...
Full story
Back to top
